SCHEMBL25832942

SCHEMBL25832942

CSc1nc(C)n2ncc(C)c2n1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.38
▸ HTT P42858 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23508414 0.84 KDM4E (0.37) KDM4EHTTHSP90AB1
SCHEMBL23497442 0.82 KDM4E (0.36) KDM4EHTT
SCHEMBL11916288 0.82 KDM4E (0.36) KDM4EHTT
SCHEMBL11916287 0.80 IKBKB (0.40) KDM4E
SCHEMBL18788176 0.66 LMNA (0.44) KDM4EHTT
SCHEMBL23508420 0.64 PDE10A (0.33) KDM4E
SCHEMBL26113070 0.64 DYRK1A (0.40) KDM4EHTT
SCHEMBL26115015 0.64 LMNA (0.43) KDM4EHTT
SCHEMBL23508158 0.63 MAPK1 (0.30) —
SCHEMBL15719036 0.63 POLB (0.41) KDM4EHSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023135057-A1 BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2023-07-20 — — WO disclosed
Send feedback